Berchuck A - Search Results

1

A framework for assessing interactions for risk stratification models: the example of ovarian cancer.

Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, Pharoah PDP, Qin B, Terry KL, Titus LJ, Webb PM, Wu AH, Zeinomar N, Ziogas A, Berchuck A, Cho KR, Hanley GE, Meza R, Mukherjee B, Pike MC, Pearce CL, Trabert B. Phung MT, et al. Among authors: berchuck a. J Natl Cancer Inst. 2023 Nov 8;115(11):1420-1426. doi: 10.1093/jnci/djad137. J Natl Cancer Inst. 2023. PMID: 37436712

2

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

3

Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.

Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC Jr. Wiener JR, et al. Among authors: berchuck a. J Natl Cancer Inst. 1994 Mar 2;86(5):372-8. doi: 10.1093/jnci/86.5.372. J Natl Cancer Inst. 1994. PMID: 7905928

4

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: berchuck a. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

5

Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.

Schildkraut JM, Bastos E, Berchuck A. Schildkraut JM, et al. Among authors: berchuck a. J Natl Cancer Inst. 1997 Jul 2;89(13):932-8. doi: 10.1093/jnci/89.13.932. J Natl Cancer Inst. 1997. PMID: 9214672

6

Human ovarian cancer of the surface epithelium.

Berchuck A, Carney M. Berchuck A, et al. Biochem Pharmacol. 1997 Sep 1;54(5):541-4. doi: 10.1016/s0006-2952(97)00061-0. Biochem Pharmacol. 1997. PMID: 9337069 Review.

7

Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2.

Berchuck A, Carney M, Lancaster JM, Marks J, Futreal AP. Berchuck A, et al. Clin Obstet Gynecol. 1998 Mar;41(1):157-66. doi: 10.1097/00003081-199803000-00022. Clin Obstet Gynecol. 1998. PMID: 9504233 Review. No abstract available.

8

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer.

Lancaster JM, Berchuck A, Carney ME, Wiseman R, Taylor JA. Lancaster JM, et al. Among authors: berchuck a. Br J Cancer. 1998 Jul;78(2):277. doi: 10.1038/bjc.1998.480. Br J Cancer. 1998. PMID: 9683307 Free PMC article. No abstract available.

9

Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.

Carney ME, Maxwell GL, Lancaster JM, Gumbs C, Marks J, Berchuck A, Futreal PA. Carney ME, et al. Among authors: berchuck a. J Soc Gynecol Investig. 1998 Sep-Oct;5(5):281-5. doi: 10.1016/s1071-5576(98)00018-5. J Soc Gynecol Investig. 1998. PMID: 9773405

10

Frequency of germline and somatic BRCA1 mutations in ovarian cancer.

Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS. Berchuck A, et al. Clin Cancer Res. 1998 Oct;4(10):2433-7. Clin Cancer Res. 1998. PMID: 9796975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page